| 23.01.2025 20:34 | AZN | AstraZeneca makes USD570 million investment in Canada in pipeline push | Alliance |
| 20.01.2025 09:56 | ABDP, SFR, SYNT | LONDON BROKER RATINGS: Jefferies raises Spirax; Peel Hunt cuts Grainger | Alliance |
| 20.01.2025 08:38 | AZN | AstraZeneca and Daiichi's Datroway wins US FDA breast cancer approval | Alliance |
| 20.01.2025 07:00 | AZN | Dato-DXd approved in US for HR+ breast cancer | RNS |
| 17.01.2025 08:16 | AZN | AstraZeneca's Calquence gets US approval for mantle cell lymphoma | Alliance |
| 17.01.2025 07:00 | AZN | Calquence combination approved in US for 1L MCL | RNS |
| 14.01.2025 12:07 | AZN, HCM | IN BRIEF: Hutchmed lung cancer treatment Orpathys approved in China | Alliance |
| 13.01.2025 09:37 | DAL, THS, WISE | LONDON BROKER RATINGS: Deutsche Bank cuts Direct Line to 'hold' | Alliance |
| 13.01.2025 09:19 | AZN | AstraZeneca and Daiichi Sankyo cheer priority US review of cancer drug | Alliance |
| 09.01.2025 11:25 | AZN | AstraZeneca breast cancer drug Lynparza given green light for NHS use | Alliance |
| 02.01.2025 15:00 | AZN | Total Voting Rights | RNS |
| 02.01.2025 10:46 | AZN, HCM | Hutchmed China disposes of 45% stake in Shanghai joint venture | Alliance |
| 27.12.2024 09:11 | AZN, SYNC | Syncona investee sells assets to AstraZeneca for USD12 million | Alliance |
| 24.12.2024 08:20 | AZN | AstraZeneca and Daiichi withdraw EU application for lung cancer drug | Alliance |
| 24.12.2024 07:00 | AZN | Dato-DXd NSQ NSCLC application withdrawn in EU | RNS |
| 23.12.2024 10:13 | AZN | AstraZeneca receives EU approval for Tagrisso lung cancer treatment | Alliance |
| 23.12.2024 07:00 | AZN | Tagrisso approved in EU based on LAURA trial | RNS |
| 18.12.2024 12:44 | AZN | PRESS: AstraZeneca sees sales slump in China after arrest of exec - FT | Alliance |
| 16.12.2024 07:00 | AZN | Directorate Change | RNS |
| 13.12.2024 10:04 | AZN, HCM | IN BRIEF: Hutchmed to get Takeda milestone payment | Alliance |
| 11.12.2024 19:40 | AZN | IN BRIEF: Merck and AstraZeneca unveil long-term Lynparza results | Alliance |
| 09.12.2024 09:09 | AZN | AstraZeneca, Daiichi Sankyo hail US breakthrough therapy designation | Alliance |
| 05.12.2024 19:52 | SURE, CLC, EMVC | EARNINGS AND TRADING: Synectics deal wins; TruFin to beat expectations | Alliance |
| 05.12.2024 09:46 | AZN | AstraZeneca touts US FDA approval for small cell lung cancer treatment | Alliance |
| 05.12.2024 07:00 | AZN | Imfinzi approved in US for limited-stage SCLC | RNS |
| 04.12.2024 21:37 | AZN | TOP NEWS: AstraZeneca appoints replacement for detained China boss | Alliance |
| 04.12.2024 13:45 | AZN | AstraZeneca appoints Iskra Reic EVP International | RNS |
| 02.12.2024 15:05 | AZN | Block listing Interim Review | RNS |
| 02.12.2024 15:00 | AZN | Total Voting Rights | RNS |
| 25.11.2024 08:51 | AZN | TOP NEWS: AstraZeneca hails positive Truqap data on prostate cancer | Alliance |
| 25.11.2024 07:00 | AZN | Truqap improved rPFS in advanced prostate cancer | RNS |
| 20.11.2024 16:00 | AZN | Director/PDMR Shareholding | RNS |
| 20.11.2024 09:53 | SGE, DPLM, INF | LONDON BROKER RATINGS: United Utilities raised; HSBC cuts easyJet | Alliance |
| 19.11.2024 15:47 | AZN | AstraZeneca "disappointed" as breast cancer drug blocked for NHS use | Alliance |
| 18.11.2024 12:43 | GRP, TBCG, AZN | DIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buy | Alliance |
| 18.11.2024 09:01 | AZN | TOP NEWS: AstraZeneca hails recommended EU approval of Tagrisso | Alliance |
| 15.11.2024 14:00 | AZN | Director/PDMR Shareholding | RNS |
| 15.11.2024 11:04 | SXS, AZN, TRIG | DIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in shares | Alliance |
| 15.11.2024 10:00 | AZN | Director/PDMR Shareholding | RNS |
| 14.11.2024 09:32 | ATYM, TTG, BAB | LONDON BROKER RATINGS: Goldman Sachs raises Dr Martens to 'neutral' | Alliance |
| 13.11.2024 16:00 | AZN | Director/PDMR Shareholding | RNS |
| 13.11.2024 09:33 | FLTR, CRE, SXS | LONDON BROKER RATINGS: Deutsche Bank raises Ibstock to 'buy' | Alliance |
| 12.11.2024 19:50 | AZN | IN BRIEF: Merck trial shows Koselugo effective in treating adults | Alliance |
| 12.11.2024 08:59 | AZN | TOP NEWS: AstraZeneca lifts annual guidance despite possible forex hit | Alliance |
| 12.11.2024 07:10 | AZN | AstraZeneca invests $3.5 billion in US | RNS |
| 12.11.2024 07:05 | AZN | KOMET Phase III trial met primary endpoint | RNS |
| 12.11.2024 07:00 | AZN | 9M and Q3 2024 Results | RNS |
| 12.11.2024 07:00 | AZN | Dato-DXd new BLA submitted, NSQ BLA withdrawn | RNS |
| 11.11.2024 12:07 | AZN, AGL | Angle notes use of Parsortix system in treatment resistance study | Alliance |
| 08.11.2024 09:13 | AZN | AstraZeneca touts positive results from nasal polyp treatment study | Alliance |
| 08.11.2024 07:00 | AZN | Tezspire nasal polyps trial met primary endpoints | RNS |
| 07.11.2024 11:14 | AZN | TOP NEWS: AstraZeneca says China chief detained as under investigation | Alliance |
| 06.11.2024 09:32 | SBRE, ASC, MGAM | LONDON BROKER RATINGS: RBC raises Burberry, Deutsche cuts AstraZeneca | Alliance |
| 05.11.2024 18:39 | AZN | TOP NEWS: AstraZeneca pledges to assist in China probe as shares slide | Alliance |
| 05.11.2024 16:49 | AZN | AZN share price movement | RNS |
| 05.11.2024 14:48 | VOD, ZOO, RWI | UK earnings, trading statements calendar - next 7 days | Alliance |
| 01.11.2024 15:00 | AZN | Total Voting Rights | RNS |
| 30.10.2024 14:30 | AZN | IN BRIEF: AstraZeneca China President Leon Wang under investigation | Alliance |
| 30.10.2024 13:00 | AZN | AZN China President under investigation | RNS |
| 28.10.2024 08:46 | AZN | AstraZeneca pleased as EU approves Fasenra for treatment of EGPA | Alliance |
| 21.10.2024 08:35 | AZN | AstraZeneca polyneuropathy treatment recommended for EU approval | Alliance |
| 16.10.2024 09:52 | AZN, HCM | TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results | Alliance |
| 14.10.2024 10:42 | AZN | TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China | Alliance |
| 08.10.2024 09:30 | HLN, AZN, BARC | LONDON BROKER RATINGS: Goldman Sachs starts Barclays at 'buy' | Alliance |
| 07.10.2024 10:20 | AZN | AstraZeneca enters agreement to strengthen cardiovascular pipeline | Alliance |
| 07.10.2024 09:30 | AZN | AstraZeneca licenses lipid lowering Lp(a) asset | RNS |
| 07.10.2024 08:52 | AZN | TOP NEWS: AstraZeneca hails Airsupra trial results to treat asthma | Alliance |
| 03.10.2024 11:01 | AZN | TOP NEWS: AstraZeneca's Calquence gets priority review in US | Alliance |
| 03.10.2024 09:39 | SFOR, OMU, MARS | LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating | Alliance |
| 01.10.2024 15:00 | AZN | Total Voting Rights | RNS |
| 01.10.2024 09:39 | AZN | TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US | Alliance |
| 26.09.2024 11:00 | AZN | TOP NEWS: AstraZeneca hails Tagrisso approval in US for cancer form | Alliance |
| 26.09.2024 07:00 | AZN | Tagrisso US approval in unresectable lung cancer | RNS |
| 25.09.2024 13:49 | AZN | Pfizer, Moderna and BioNTech take patent fight to Court of Appeal | Alliance |
| 23.09.2024 08:44 | AZN | TOP NEWS: AstraZeneca cancer drug fails to significantly extend lives | Alliance |
